PTN

Palatin Technologies

20.21 USD
0.00
0%
At close Updated Apr 30, 4:00 PM EDT
1 day
0%
5 days
-7.67%
1 month
17.5%
3 months
17.16%
6 months
83.06%
Year to date
25.92%
1 year
85.41%
5 years
-97.37%
10 years
-97.1%
 

About: Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.

Employees: 29

0
Funds holding %
of 8,127 funds
Analysts bullish %
Positive news %
Price charts implemented using Lightweight Charts™